Search review questions

Periodontal parameters (all measures pooled) in OC cases vs controls · Adults in case-control studies (oral cancer patients vs healthy controls) · Not specified, Overall (all periodontal measures pooled)

Streptococcus mutans salivary/plaque counts (cariogenic microbiota) · Children and adolescents aged 0-18 years with non-syndromic cleft lip and palate (CLP)

Overjet · Children and adolescents (aged 16 years or younger) with prominent lower front teeth (Class III malocclusion) · End of treatment

Child microbiological presence (any mutans streptococci colonisation) · For interventions, pregnant women and mothers of infants in the first year of life; for outcomes, children up to 6…

Overjet · Children and adolescents (aged 16 years or younger) with prominent lower front teeth (Class III malocclusion) · End of treatment (9 to 15 months)

Prevention of new caries (caries development/increment) · Preschool children (primary dentition) at risk of new caries · 6 to 18 months

Change in clinical attachment level (CAL) · Adults (> 18 years) with a clinical diagnosis of periodontitis, receiving active (non-surgical anti-infective) treatment · 3 months (change from baseline)

Recurrence rate · People with temporomandibular disorders (TMD)

Child oral health behaviours · For interventions, pregnant women, mothers or other caregivers of infants in the first year of life; for outcomes,…

Early childhood caries (ECC) prevalence (%, dmft>0) · Children younger than 71 months (under 6 years) · Region: Europe

Fluorosis (percentage prevalence in permanent teeth) · Children exposed to topical fluoride when under 6 years old; fluorosis assessed in permanent teeth at 6 to 18 years · Fluorosis assessed when most permanent teeth of interest had erupted (6 to 18 years)

Dental caries · Children (<18 years) with vs without dental caries · Dominant model (TT+TC vs CC), Primary dentition

Self-reported joint pain when chewing · People with temporomandibular disorders (TMD)

Wits appraisal · Children and adolescents (aged 16 years or younger) with prominent lower front teeth (Class III malocclusion) · End of treatment

Participant-reported resumption of normal eating, chewing and speech · People of any age with a confirmed diagnosis, by clinical examination and biopsy, of oral submucous fibrosis (OSF)

Overall success (composite of clinical and radiographic success) · Permanent teeth with carious pulp exposure · >=12 months, Hemostasis unknown

Alignment rate · People receiving orthodontic treatment with fixed appliances (upper and/or lower full arch) · 4 weeks

Spontaneous space closure · Children and adolescents after extraction of a mandibular permanent first molar (before eruption of the second molar) · Until eruption of the permanent second molar (median follow-up 4.0 years), Mandible

Pain at 24 hours · Adults with a symptomatic necrotic tooth or localised acute apical abscess (no signs of spreading infection or… · 24 hours

Dental caries · Children (<18 years) with vs without dental caries · Recessive model (TT vs TG+GG)

Dental caries · Children (<18 years) with vs without dental caries · Dominant model (TT+TC vs CC), PCR-RFLP genotyping

Spontaneous space closure · Children and adolescents (<18 years) after extraction of a permanent first molar before eruption of the permanent… · Until eruption of the permanent second molar (median follow-up 4.0 years), Maxilla

Adverse effects · Children and adults (with or without carious lesions) · 12 months, Children

Bacterial plaque index · Children and/or adolescents (<18 years) without background systemic disease · Probiotic presentation: milk (vs other presentations; p-interaction=0.01)

Adverse effects · Children and adults (with or without carious lesions) · 24 months, Children

Adverse effects · People of any age with a confirmed diagnosis, by clinical examination and biopsy, of oral submucous fibrosis (OSF)

Dental caries, prevalence · Primary school children in Ethiopia · Sampling technique: multi-stage random sampling

ANB · Children and adolescents (aged 16 years or younger) with prominent lower front teeth (Class III malocclusion) · End of treatment

Dental caries · Children (<18 years) with vs without dental caries · Allelic model (G vs A)

Maximal mouth opening (interincisal distance) · People of any age with a confirmed diagnosis, by clinical examination and biopsy, of oral submucous fibrosis (OSF) · 3 to 6 months

Recurrence rate · People with temporomandibular disorders (TMD)

Serum vitamin D (25(OH)D): ECC vs caries-free · Region: Asia (Fig 4)

dmfs index score · For interventions, pregnant women and mothers of infants in the first year of life; for outcomes, children up to 6…

Dental pain or sensitivity · Children and adults (with or without carious lesions) · 3 months, Children

Caries arrest · Children and adults (with or without carious lesions) · 12 to 30 months, Primary dentition

Swelling at 48 hours · Adults with a symptomatic necrotic tooth or localised acute apical abscess (no signs of spreading infection or… · 48 hours

Enamel demineralization (DIAGNOdent) · Patients undergoing fixed orthodontic (fixed appliance) treatment (adolescents and adults, ages 12 to 35) · 1 and 6 months

Recurrence rate · People with temporomandibular disorders (TMD)

Dental service utilisation within the past year · Adult residents of slums and non-slum urban settings of LMICs · Past 12 months

Discomfort · People with temporomandibular disorders (TMD)

Dental caries / early childhood caries (ECC) · Children (approx. 4-18 years) · Adjustment for age: yes

ANB · Children and adolescents (aged 16 years or younger) with prominent lower front teeth (Class III malocclusion) · End of treatment

Caries arrestment at the surface level · Children and adults with active dental caries (aged 1-50; mostly preschool/school children with primary dentition) · 12 to 18 months, SDF vs NAF

Self-esteem (Piers-Harris self-concept scale) · Children and adolescents (aged 16 years or younger) with prominent lower front teeth (Class III malocclusion) · 3-year follow-up

Overall success (composite of clinical and radiographic success) · Immature teeth, unspecified/mixed diagnosis

Maximal mouth opening (interincisal distance) · People of any age with a confirmed diagnosis, by clinical examination and biopsy, of oral submucous fibrosis (OSF) · More than 6 months

ANB · Children and adolescents (aged 16 years or younger) with prominent lower front teeth (Class III malocclusion) · End of treatment

Antibacterial effect (Streptococcus mutans count, real-time PCR) · Patients undergoing fixed orthodontic (fixed appliance) treatment (adolescents and adults, ages 12 to 35) · 1 day to 6 months, Antibacterial (S. mutans)

Severity of joint noise · People with temporomandibular disorders (TMD)

Overall success (composite of clinical and radiographic success) · Partial pulpotomy, normal pulp/reversible pulpitis